Fundz

Dr. Alexandra Miller

PRIVATEFeb 09, 2024

Position

Director

Company

NYU Langone’s Perlmutter Cancer Center

Alexandra Miller
BiotechnologyHealth CareMedicalNon Profit

Description

NYU Langone’s Perlmutter Cancer Center appoints Alexandra Miller, MD, PhD as chief of neuro-oncology and co-director of Brain & Spine Tumor Center.

Quick answer

Dr. Alexandra Miller (February 9, 2024).

Who is the new Director at NYU Langone’s Perlmutter Cancer Center?
NYU Langone’s Perlmutter Cancer Center named Alexandra Miller Director, announced February 9, 2024.
What did NYU Langone’s Perlmutter Cancer Center announce on February 9, 2024?
NYU Langone’s Perlmutter Cancer Center appoints Alexandra Miller, MD, PhD as chief of neuro-oncology and co-director of Brain & Spine Tumor Center.
What does NYU Langone’s Perlmutter Cancer Center do?
NYU Langone’s Perlmutter Cancer Center is a renowned medical center that specializes in comprehensive care and treatment advances for cancer patients.
Which similar companies made leadership changes around the same time?
Roswell Park Comprehensive Cancer Center (February 29, 2024), United Wholesale Mortgage (March 25, 2024), Memorial Regional Hospital South (February 9, 2024) and agilon health (February 8, 2024) also announced leadership changes within 45 days of NYU Langone’s Perlmutter Cancer Center.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Non Profit

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at NYU Langone’s Perlmutter Cancer Center, and when

A new leader at NYU Langone’s Perlmutter Cancer Center brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day NYU Langone’s Perlmutter Cancer Center raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NYU Langone’s Perlmutter Cancer Center, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NYU Langone’s Perlmutter Cancer Center. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NYU Langone’s Perlmutter Cancer Center

About

NYU Langone’s Perlmutter Cancer Center is a renowned medical center that specializes in comprehensive care and treatment advances for cancer patients. The center has a long-standing reputation as a national and international leader in the treatment of brain tumors, spinal cord tumors, and skull base tumors in adults and children.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NYU Langone’s Perlmutter Cancer Center changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for NYU Langone’s Perlmutter Cancer Center's next move

Learn about Strategic plan

NYU Langone’s Perlmutter Cancer Center changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.